Biomarkers of dietary exposure are associated with lower risk of breast fibroadenomas in Chinese women

Journal of Nutrition

Volumn 140, Issue 7, 2010, Pages 1302-1310

  Dijkstra, S Coosje ^a,b   Lampe, Johanna W ^a   Ray, Roberta M ^a   Brown, Rose ^a   Wu, Chunyuan ^a   Li, Wenjin ^a   Chen, Chu ^a   King, Irena B ^a   Gao, Daoli ^c   Hu, Yongwei ^d   Shannon, Jackilen ^e   Wähälä, Kristiina ^f   Thomas, David B ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^d Shidong Hospital   (China)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CAROTENOID; DAIDZEIN; FATTY ACID; FERRITIN; GENISTEIN;

ADULT; ARTICLE; BREAST FIBROADENOMA; BREAST SELF EXAMINATION; CANCER RISK; CHINA; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FERRITIN BLOOD LEVEL; FISH; HUMAN; MAJOR CLINICAL STUDY; SOYBEAN; VITAMIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; DIET; FEMALE; FIBROADENOMA; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 77953743819     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.119727     Document Type: Article

References (53)

1. Greenberg R, Skornick Y, Kaplan O. Management of breast fibroadenomas. J Gen Intern Med. 1998;13:640-5.
2. Schuerch C III, Rosen PP, Hirota T, Itabashi M, Yamamoto H, Kinne DW, Beattie EJ Jr. A pathologic study of benign breast diseases in Tokyo and New York. Cancer. 1982;50:1899-903.
3. Cunningham LL, Andrykowski MA, Wilson JF, McGrath PC, Sloan DA, Kenady DE. Physical symptoms, distress, and breast cancer risk perceptions in women with benign breast problems. Health Psychol. 1998;17:371-5.
4. Hislop TG, Elwood JM. Risk factors for benign breast disease: a 30-year cohort study. Can Med Assoc J. 1981;124:283-91.
5. Chang DS, McGrath MH. Management of benign tumors of the adolescent breast. Plast Reconstr Surg. 2007;120:13e-9e.
6. Coriaty Nelson Z, Ray RM, Gao DL, Thomas DB. Risk factors for fibroadenoma in a cohort of female textile workers in Shanghai, China. Am J Epidemiol. 2002;156:599-605.
7. Cole P, Mark Elwood J, Kaplan SD. Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol. 1978;108:112-20. (Pubitemid 9148064)
8. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146-51.
9. Carter BA, Page DL, Schuyler P, Parl FF, Simpson JF, Jensen RA, Dupont WD. No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. Cancer. 2001;92:30-6.
10. Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD Jr, Rados MS, Schuyler PA. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994;331:10-5.
11. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229-37.
12. Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N. Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst. 2004;96:616-20. (Pubitemid 38584985)
13. Dorjgochoo T, Deming SL, Gao YT, Lu W, Zheng Y, Ruan Z, Zheng W, Shu XO. History of benign breast disease and risk of breast cancer among women in China: a case-control study. Cancer Causes Control. 2008; 19:819-28.
14. Yu H, Rohan TE, Cook MG, Howe GR, Miller AB. Risk factors for fibroadenoma: a case-control study in Australia. Am J Epidemiol. 1992;135:247-58.
15. Sartwell PE, Arthes FG, Tonascia JA. Benign and malignant breast tumours: epidemiological similarities. Int J Epidemiol. 1978;7:217-21.
16. Brinton LA, Vessey MP, Flavel R, Yeates D. Risk factors for benign breast disease. Am J Epidemiol. 1981;113:203-14. (Pubitemid 11152571)
17. Berkowitz GS, Canny PF, Vivolsi VA,Merino MJ, O'Connor TZ, Kelsey JL. Cigarette smoking and benign breast disease. J Epidemiol Community Health. 1985;39:308-13.
18. Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs TW, Baer HJ, Willett WC, Colditz GA. A prospective study of diet and benign breast disease. Cancer Epidemiol Biomarkers Prev. 2004;13:1106-13. (Pubitemid 38917898)
19. Rohan TE, Cook MG, Potter JD, McMichael AJ. A case-control study of diet and benign proliferative epithelial disorders of the breast. Cancer Res. 1990;50:3176-81.
20. Lubin F, Wax Y, Ron E, Black M, Chetrit A, Rosen N, Alfandary E, Modan B. Nutritional factors associated with benign breast disease etiology: a case-control study. Am J Clin Nutr. 1989;50:551-6. (Pubitemid 19228921)
21. Wu C, Ray RM, Lin MG, Gao DL, Horner NK, Nelson ZC, Lampe JW, Hu YW, Shannon J, et al. A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. Am J Epidemiol. 2004;160:945-60.
22. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, Porter P, Hu YW, Zhao GL, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002;94:1445-57.
23. Coriaty Nelson Z, Ray RM, Wu C, Stalsberg H, Porter P, Lampe JW, Shannon J, Homer N, Li W, et al. Fruit and vegetable intakes are associated with lower risk of breast fibroadenomas in Chinese women. J Nutr. 2010;1294-1301.
24. Frankenfeld CL, Lampe JW, Shannon J, Gao DL, Ray RM, Prunty J, Kalhorn TF, Wähälä K, Patterson RE, et al. Frequency of soy food consumption and serum isoflavone concentrations among Chinese women in Shanghai. Public Health Nutr. 2004;7:765-72.
25. Kalman DA, Goodman GE, Omenn GS, Bellamy G, Rollins B. Micronutrient assay for cancer prevention clinical trials: serum retinol, retinyl palmitate, alpha-carotene, and beta-carotene with the use of high-performance liquid chromatography. J Natl Cancer Inst. 1987;79:975-82. (Pubitemid 17165267)
26. Zhang C, Williams MA, Sanchez SE, King IB, Ware-Jauregui S, Larrabure G, Bazul V, Leisenring WM. Plasma concentrations of carotenoids, retinol and tocopherols in preeclamptic and normotensive pregnant women. Am J Epidemiol. 2001;153:572-80.
27. Shannon J, King IB, Moshofsky R, Lampe JW, Gao DL, Ray RM, Thomas DB. Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am J Clin Nutr. 2007;85:1090-7.
28. Moore AB, Shannon J, Chen C, Lampe JW, Ray RM, Lewis SK, Lin MG, Stalsberg H, Thomas DB. Dietary and stored iron as predictors of breast cancer risk: a case control study in Shanghai. Int J Cancer. 2009;125:1110-7.
29. Szklo M, Nieto FJ. Epidemiology: beyond the basics. Gaithersburg (MD): Aspen Publishers Inc., 2000.
30. Chajes V, Hulten K, Van Kappel AL, Winkvist A, Kaaks R, Hallmans G, Lenner P, Riboli E. Fatty-acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden. Int J Cancer. 1999;83:585-90.
31. Pala V, Krogh V, Muti P, Chajes V, Riboli E, Micheli A, Saadatian M, Sieri S, Berrino F. Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst. 2001;93:1088-95.
32. Breslow NE. Statistics in epidemiology: the case-control study. J Am Stat Assoc. 1996;91:14-28.
33. Li W, Ray RM, Lampe JW, Lin MG, Gao DL, Wu C, Nelson ZC, Fitzgibbons ED, Horner N, et al. Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. Int J Cancer. 2005;115:981-93.
34. Lampe JW, Nishino Y, Ray RM, Wu C, Li W, Lin MG, Gao DL, Hu Y, Shannon J, et al. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2007;16:2579-86.
35. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008;98:9-14.
36. Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, Miura T, Yamamoto S, Tsugane S. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol. 2008;26:1677-83.
37. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, Cheng J, Gao YT, Zheng W. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev. 2002;11:815-21. (Pubitemid 35014883)
38. Warri A, Saarinen NM, Makela S, Hilakivi-Clarke L. The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer. 2008;98:1485-93.
39. Baer HJ, Schnitt SJ, Connolly JL, Byrne C, Willett WC, Rosner B, Colditz GA. Early life factors and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev. 2005;14:2889-97.
40. Byrne C, Webb PM, Jacobs TW, Peiro G, Schnitt SJ, Connolly JL, Willett WC, Colditz GA. Alcohol consumption and incidence of benign breast disease. Cancer Epidemiol Biomarkers Prev. 2002;11:1369-74. (Pubitemid 35340371)
41. Wu AH, Koh WP, Wang R, Lee HP, Yu MC. Soy intake and breast cancer risk in Singapore Chinese Health Study. Br J Cancer. 2008;99:196-200.
42. Rohan TE, Jain M, Miller AB. A case-cohort study of diet and risk of benign proliferative epithelial disorders of the breast (Canada). Cancer Causes Control. 1998;9:19-27. (Pubitemid 28048656)
43. Jan KC, Ho CT, Hwang LS. Bioavailability and tissue distribution of sesamol in rat. J Agric Food Chem. 2008;56:7032-7.
44. Shannon J, King IB, Lampe JW, Gao DL, Ray RM, Lin MG, Stalsberg H, Thomas DB. Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai. Am J Clin Nutr. 2009;89:265-76.
45. Whelan J, Rust C. Innovative dietary sources of n-3 fatty acids. Annu Rev Nutr. 2006;26:75-103.
46. Satia JA, Patterson RE, Herrero R, Jin F, Dai Q, King IB, Chen C, Kristal AR, Prentice RL, et al. Study of diet, biomarkers and cancer risk in the United States, China and Costa Rica. Int J Cancer. 1999;82:28-32.
47. Benistant C, Achard F, Ben Slama S, Lagarde M. Docosapentaenoic acid (22:5,n-3): metabolism and effect on prostacyclin production in endothelial cells. Prostaglandins Leukot Essent Fatty Acids. 1996;55:287-92.
48. Pollard J, Wild CP, White KL, Greenwood DC, Cade JE, Kirk SF. Comparison of plasma biomarkers with dietary assessment methods for fruit and vegetable intake. Eur J Clin Nutr. 2003;57:988-98.
49. Campbell DR, Gross MD, Martini MC, Grandits GA, Slavin JL, Potter JD. Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev. 1994;3:493-500. (Pubitemid 24280973)
50. Kumaraguruparan R, Subapriya R, Kabalimoorthy J, Nagini S. Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin Biochem. 2002;35:275-9.
51. Kabat GC, Rohan TE. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis. Cancer Causes Control. 2007;18:1047-53.
52. Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet. 2009;125:507-25.
53. Takei H, Iino Y, Horiguchi J, Maemura M, Yokoe T, Koibuchi Y, Oyama T, Ohwada S, Morishita Y. Natural history of fibroadenomas based on the correlation between size and patient age. Jpn J Clin Oncol. 1999;29:8-10.